Here is the Minister of Health’s response to our petition. It is encouraging that the Minister recognizes psychedelics are now visible on the horizon. CIHR is the Canadian Institutes of Health Research, which is the research funding arm of the Ministry of Health.
“CIHR is committed to supporting the development of novel mental health treatments and interventions. In the case of psychedelics, which are restricted drugs under the Controlled Drugs and Substances Act, researchers must obtain an exemption from Health Canada for authorization to possess a specific quantity of a controlled substance to be used solely for scientific purposes outlined in their proposal.
CIHR recognizes the importance of funding research on novel compounds for treatment of mental health disorders and invites researchers to continue to apply to relevant CIHR funding competitions to build upon this important work.”
So, put together a funding proposal!
Read the full response on the petition website
Psychedelic-assisted therapies have shown clear promise as breakthrough interventions for treatment-resistant post-traumatic stress disorder, treatment-resistant major depressive disorder, end-of-life anxiety in terminally ill cancer patients, and various substance addiction disorders (ranging from nicotine, to alcohol, to opioids).
Please sign this petition to advance the state of mental health research and make Canada once again, a world leader in psychiatric treatment.
Here is the petition in its entirety:
- Globally – and within Canada – a multitude of pilot studies and controlled clinical trials have established clear and experimentally-validated protocols for the safe use of psychedelics in clinical-therapeutic contexts.
- Psychedelic-assisted psychotherapies have shown clear promise as breakthrough interventions for treatment-resistant post-traumatic stress disorder, treatment resistant major depressive disorder, end-of-life anxiety in terminally ill cancer patients, and various substance addiction disorders (ranging from nicotine to alcohol to opioids) – debilitating conditions that the Parliamentary Information service’s studies have concluded to cost the country well over $50 billion annually.
- Psychedelic compounds, and the plant sources they are derived from, cannot be patented, and as such, there is no incentive for pharmaceutical companies to invest in the development of these treatments despite a rapidly growing body of evidence supporting their effectiveness.
- As such, clinical research using psychedelics thus requires robust public funding in order to progress. Such funding would help to establish Canada as a world leader in the development of novel mental health treatments and interventions.
- Therefore, given the strong precedent for the safe use of psychedelics in controlled-clinical settings,
We, the undersigned, Citizens of Canada, call upon the Minister of Health to request that the Minister acknowledge the potential for psychedelic research to generate novel and effective treatment options for these – and likely various other conditions – and to commit significant, multi-year, funding for major psychedelic research projects at hospitals and universities across Canada.
Sign the petition here in English or in French. If you would like to help us gather signatures, use the links above on a tablet so signatories can fill in their details, or print these QR Codes so people can snap them with their phones:
Join the discussion on Facebook. Here’s Dan Greig of CSSDP U of T talking about psychedelic research at the recent Mapping the Mind With Mushrooms conference on Sept. 23. Share it with a link to the petition.
Nick Clark generously donated his time to create this image.
Share it with a link to the petition
Dr. Robin Carhart-Harris will be speaking in Toronto at the university of Toronto on October 30th, giving a talk called “Can Magic Mushrooms Treat Depression?” Tickets are available at the psychedelic speakers tab on the menu.
Carhart-Harris et al, Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study, The Lancet, 2016.
Dos Santos et al, Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years, NIH, 2016.
Kenneth Tupper, et al, Psychedelic medicine: a re-emerging therapeutic paradigm, CMAJ, 2016.
Robin L Carhart-Harris1 and Guy M Goodwin, The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future, 2017
Maps news: Breakthrough therapy news
Michael Pollan. The Trip Treatment: New Research on the Healing Properties of Psychedelics. The New School, 2016
British Columbia looks to Portugal to combat opioid crisis – Globe and Mail
CBC Quirks and Quarks – Interviews with Dr. Mark Blier and Dr. David Nutt, March, 2017
NYU researchers talk about their experience with psychedelic research, Horizons Conference, NYC, Oct. 2017
Vancouver – Mark Haden – Maps
Adjunct Professor UBC School of Population and Public Health
Executive Director of MAPS Canada
Ottawa – Paul Grof, MD, PhD, FRCP
Director, Mood Disorders Center of Ottawa
Associate Editor, Canadian Journal of Psychiatry
Professor of Psychiatry, University of Toronto
Montreal – Jean-Sebastian Fallu
Universite de Montreal
The Petition has spawned dozens of articles in the press:
Fund research for psychedelic drugs: experts – Sachem.ca
Fund research for psychedelic drugs: experts – Hamilton Spectator
Feds urged to back research on psychedelic drugs for medical treatments – Waterloo Chronicle
Fund research for psychedelic drugs: experts – My Kwartha
Fund research for psychedelic drugs: experts – Inside Belleville
Fund research for psychedelic drugs: experts – Our Perth
Feds urged to back research on psychedelic drugs for medical treatments– Pentiction Herald
Fund research for psychedelic drugs: experts – DurhamRegion.com
Feds urged to back research on psychedelic drugs for medical treatments – New Hamburg Independent
Fund research for psychedelic drugs: experts – TheIFP.ca
<iframe src=”https://globalnews.ca/video/embed/2506876/” width=”670″ height=”372″ frameborder=”0″ allowfullscreen scrolling=”no”></iframe>